Aclarion authorizes $2.5 million share repurchase program over 12 months

Aclarion, Inc.

Board authorized repurchase of up to $2.5M in common stock over next 12 months.
CEO Brent Ness says current valuation does not reflect full strength of Nociscan platform.
Company had $19.0M cash as of March 31, 2026; repurchase funded from existing cash.
Program may be executed via open market purchases, block trades, 10b5-1 plans, or private deals.
Management believes cash runway supports milestones including CLARITY trial initial milestone.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.